Poster Presentation Guidelines
Poster Session Format
All accepted abstracts will be presented as posters.
Presenters should be prepared to:
-
deliver a concise 3-5 minute overview of their work,
-
discuss their findings with judges and attendees,
-
answer scientific questions regarding the project.
Presenters are expected to remain at their posters during the assigned judging session.
Poster Dimensions
Posters must be in landscape orientation.
Maximum dimensions:
-
48 inches (width)
-
36 inches (height)
Posters exceeding these dimensions may not fit the assigned boards.
Recommended Poster Structure
Suggested sections:
-
Title & Authors
-
Introduction/Background
-
Objective/Hypothesis
-
Methods
-
Results
-
Conclusions
-
Acknowledgements and/or Funding
-
References (optional)
Poster Design Recommendations
Recommended Font Sizes
|
Section |
Recommended Size |
|---|---|
|
Title |
72–100 pt |
|
Section Headers |
32–40 pt |
|
Body Text |
24–30 pt |
|
Figure Labels |
≥20 pt |
Design Recommendations
-
Prioritize figures over excessive text
-
Use high-resolution images
-
Maintain visual hierarchy
-
Ensure readability from approximately 4–6 feet away
-
Avoid overcrowding
-
Use consistent formatting throughout the poster
Poster Presentation Evaluation
Poster Evaluation Rubric (100 points)
|
Category |
Points |
|---|---|
|
Scientific Content & Rigor |
35 |
|
Poster Design & Visual Organization |
20 |
|
Presentation & Scientific Discussion |
25 |
|
Translational Relevance & Overall Impact |
20 |
Poster Judging Criteria
Scientific Content & Rigor (35)
Evaluation of scientific rationale, methodological quality, data interpretation, and scientific accuracy.
Poster Design & Visual Organization (20)
Evaluation of readability, organization, figure quality, visual clarity, and effective communication of data.
Presentation & Scientific Discussion (25)
Evaluation of communication skills, understanding of the project, ability to answer questions, and scientific discussion and critical thinking.
Translational Relevance & Overall Impact (20)
Evaluation of scientific significance, pharmaceutical relevance, innovation, and potential biomedical or translational impact.